Helix BioPharma Corp News - HBP

Helix BioPharma Corp. Closes $3.0 Million Private Placement

RICHMOND HILL, Ontario, Jan. 13, 2020 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX: “HBP”) (“Helix” or the...

Helix BioPharma Corp. to Present at the Biotech Showcase Conference in San Francisco

RICHMOND HILL, Ontario, Jan. 08, 2020 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX: “HBP”) (“Helix” or the...

Helix BioPharma Corp. Announces Fiscal First Quarter 2020 Results

RICHMOND HILL, Ontario, Dec. 13, 2019 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX, FSE: “HBP”), a an...

Helix BioPharma Corp. Commences L-DOS47 Phase lb/ll Pancreatic Cancer Clinical Study

RICHMOND HILL, Ontario, Dec. 11, 2019 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX: HBP), (FSE: HBP...

Helix BioPharma Corp. Reports Voting Results

RICHMOND HILL, Ontario, Dec. 06, 2019 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX: “HBP”) (“Helix” or the...

Helix BioPharma Corp. Announces Fiscal 2019 Year-End Results

RICHMOND HILL, Ontario, Oct. 25, 2019 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX: “HBP”), an...

Helix BioPharma Corp. Board Changes

RICHMOND HILL, Ontario, Oct. 10, 2019 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX: “HBP”) (“Helix” or the...

Helix BioPharma Corp. and Moffit Cancer Centre to Present at World Molecular Imaging Congress

RICHMOND HILL, Ontario, Sept. 03, 2019 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX: HBP), (“Helix” or the...

Helix BioPharma Corp. Closes $7.0 Million Private Placement

RICHMOND HILL, Ontario, Aug. 21, 2019 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX: “HBP”) (“Helix” or the...

Helix Biopharma Corp. Receives U.S. FDA Approval for Phase Ib/II Pancreatic Trial

RICHMOND HILL, Ontario, Aug. 07, 2019 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX: HBP), (“Helix” or the...

Helix Biopharma Corp. to Present at RHK Capital Conference in New York

RICHMOND HILL, Ontario, July 24, 2019 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX: HBP), (“Helix” or the...

Helix BioPharma Corp. Submits L-DOS47 IND Application With U.S. FDA for Pancreatic Cancer

RICHMOND HILL, Ontario, July 09, 2019 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX: HBP), (“Helix” or the...

Helix BioPharma Corp. Announces Fiscal Third Quarter 2019 Results

RICHMOND HILL, Ontario, June 11, 2019 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX: HBP) (“Helix” or the...

Helix BioPharma Corp. Initiates OTCQB Application and Hires U.S. Investor Relations Firm

RICHMOND HILL, Ontario, May 30, 2019 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX: HBP), (“Helix” or the...

Helix BioPharma Corp. Closes Private Placement

RICHMOND HILL, Ontario, May 29, 2019 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX: “HBP”) (“Helix” or the...

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Helix BioPharma Corp (HBP)

Professional-Grade Tools, for Individual Investors.

HBP News

Helix BioPharma Corp. Closes $3.0 Million Private Placement

Helix BioPharma Corp. to Present at the Biotech Showcase Conference in San Francisco

Helix BioPharma Corp. Announces Fiscal First Quarter 2020 Results

Helix BioPharma Corp. Commences L-DOS47 Phase lb/ll Pancreatic Cancer Clinical Study

Helix BioPharma Corp. Reports Voting Results

Helix BioPharma Corp. Announces Fiscal 2019 Year-End Results

Helix BioPharma Corp. Board Changes

Helix BioPharma Corp. and Moffit Cancer Centre to Present at World Molecular Imaging Congress

Helix BioPharma Corp. Closes $7.0 Million Private Placement

Helix Biopharma Corp. Receives U.S. FDA Approval for Phase Ib/II Pancreatic Trial

Helix Biopharma Corp. to Present at RHK Capital Conference in New York

Helix BioPharma Corp. Submits L-DOS47 IND Application With U.S. FDA for Pancreatic Cancer

Helix BioPharma Corp. Announces Fiscal Third Quarter 2019 Results

Helix BioPharma Corp. Initiates OTCQB Application and Hires U.S. Investor Relations Firm

Helix BioPharma Corp. Closes Private Placement

HBP Discussion

Your Recent History

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Helix BioPharma Corp (HBP) News

Helix BioPharma Corp (HBP)

Professional-Grade Tools, for Individual Investors.

HBP News

Helix BioPharma Corp. Closes $3.0 Million Private Placement

Helix BioPharma Corp. to Present at the Biotech Showcase Conference in San Francisco

Helix BioPharma Corp. Announces Fiscal First Quarter 2020 Results

Helix BioPharma Corp. Commences L-DOS47 Phase lb/ll Pancreatic Cancer Clinical Study

Helix BioPharma Corp. Reports Voting Results

Helix BioPharma Corp. Announces Fiscal 2019 Year-End Results

Helix BioPharma Corp. Board Changes

Helix BioPharma Corp. and Moffit Cancer Centre to Present at World Molecular Imaging Congress

Helix BioPharma Corp. Closes $7.0 Million Private Placement

Helix Biopharma Corp. Receives U.S. FDA Approval for Phase Ib/II Pancreatic Trial

Helix Biopharma Corp. to Present at RHK Capital Conference in New York

Helix BioPharma Corp. Submits L-DOS47 IND Application With U.S. FDA for Pancreatic Cancer

Helix BioPharma Corp. Announces Fiscal Third Quarter 2019 Results

Helix BioPharma Corp. Initiates OTCQB Application and Hires U.S. Investor Relations Firm

Helix BioPharma Corp. Closes Private Placement

HBP Discussion

Your Recent History